Join Oakwood Labs for a complimentary webinar on August 24^th, 2021 at 11 a.m. EST. This webinar will discuss a corporate overview and Oakwood’s approach to development of extended-release and long-acting injectables.

Oakwood’s capabilities include the following:

• Pre-formulation development activities
• Feasibility studies
• Scale-up of formulation
• Manufacturing toxicology batches
• ICH compliant stability testing
• Clinical trial manufacturing (Phase I, II, III)
• Commercial aseptic GMP manufacturing

Reach Out to Oakwood Labs Today About Extended-Release Injectables

Contact us today to learn more about the extended-release solutions we can provide for your company. We look forward to hearing from you.